Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Nevro Corp ( (NVRO) ) has provided an announcement.
On April 3, 2025, Nevro Corp, a company involved in the medical technology sector, completed a merger with Globus, resulting in Nevro becoming a wholly owned subsidiary of Globus. In conjunction with this merger, Nevro terminated its $200 million credit agreement, repaid approximately $227.1 million, and requested the delisting of its shares from the NYSE. Additionally, Nevro’s board of directors resigned, and new directors from Merger Sub were appointed, while Nevro’s incorporation documents were amended.
More about Nevro Corp
YTD Price Performance: 57.41%
Average Trading Volume: 1,242,228
Technical Sentiment Signal: Strong Buy
Current Market Cap: $224.1M
See more data about NVRO stock on TipRanks’ Stock Analysis page.